Five companies, who in the main specialise in medicine and information technology, have signed cooperation agreements worth 3.7 billion yuan ($ 590 million) representing a second round of investment into the Singapore-Sichuan High-Tech Innovation Park. These include the Hong Leong Group, Beijing TRS Information Technology Ltd, Good Doctor Pharmaceutical Group, Nanjing, Sample Technology Group and Chengdu Aipu Internet Ltd.
This follows cooperation agreements back in February signed up to by another five partners, involving a total investment of 6.7 billion yuan.
The Singapore-Sichuan Hi-Tech Innovation Park covers an area of around 10.34 square kilometres and the project aims to attract a residential population of around 120,000 and an emploped population of around 150,000. Work started on the project in May 2012 and completion is scheduled for 2020 following a total investment of RMB 100 billion.